Lensar (LNSR) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.77% |
| Dec 31, 2025 | 6.13% |
| Sep 30, 2025 | 153.39% |
| Jun 30, 2025 | -1,510.92% |
| Mar 31, 2025 | -73.34% |
| Dec 31, 2024 | 320.11% |
| Sep 30, 2024 | 55.24% |
| Jun 30, 2024 | -64.93% |
| Mar 31, 2024 | 69.08% |
| Dec 31, 2023 | -198,150.00% |
| Sep 30, 2023 | 98.90% |
| Jun 30, 2023 | -2,162.50% |
| Mar 31, 2023 | 85.96% |
| Dec 31, 2022 | -2,750.00% |
| Sep 30, 2022 | 80.00% |
| Jun 30, 2022 | 78.26% |
| Mar 31, 2022 | 70.51% |
| Dec 31, 2021 | -143.75% |
| Sep 30, 2021 | -220.00% |
| Jun 30, 2021 | 82.46% |
| Mar 31, 2021 | -8.57% |
| Dec 31, 2020 | -850.00% |
| Sep 30, 2020 | 109.86% |
| Jun 30, 2020 | -52.69% |
| Mar 31, 2020 | -30.99% |